Oxytocin May be Superior to Gliptins as a Potential Treatment for Diabetic COVID-19 Patients
Diabetes is a comorbidity associated with an increased risk of severe COVID-19. Gliptins are anti-diabetic drugs that inhibit dipeptidyl peptidase-4 (DPP4) and they have been proposed as a possible treatment for COVID-19 patients with and without diabetes due to their immunomodulatory properties. Ox...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ital Publication
2021-01-01
|
| Series: | SciMedicine Journal |
| Subjects: | |
| Online Access: | https://www.scimedjournal.org/index.php/SMJ/article/view/181 |